Ba-Ssalamah A - Search Results

1

Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.

Bareck E, Ba-Ssalamah A, Brodowicz T, Eisterer W, Häfner M, Högenauer C, Kastner U, Kühr T, Längle F, Liegl-Atzwanger B, Schoppmann SF, Widmann G, Wrba F, Zacherl J, Ploner F; Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine. Bareck E, et al. Wien Med Wochenschr. 2013 Mar;163(5-6):137-52. doi: 10.1007/s10354-013-0187-3. Epub 2013 Mar 19. Wien Med Wochenschr. 2013. PMID: 23508516

2

Dedicated multi-detector CT of the esophagus: spectrum of diseases.

Ba-Ssalamah A, Zacherl J, Noebauer-Huhmann IM, Uffmann M, Matzek WK, Pinker K, Herold C, Schima W. Ba-Ssalamah A, et al. Abdom Imaging. 2009 Jan-Feb;34(1):3-18. doi: 10.1007/s00261-007-9290-5. Abdom Imaging. 2009. PMID: 17653787 Review.

3

Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology Group Study ESGAS.1.2.001.

Hejna M, Raderer M, Zacherl J, Ba-Ssalamah A, Püspök A, Schmidinger M, Pluschnig U, Brodowicz T, Zielinski CC. Hejna M, et al. Anticancer Drugs. 2008 Jun;19(5):535-9. doi: 10.1097/CAD.0b013e3282fb178a. Anticancer Drugs. 2008. PMID: 18418220 Clinical Trial.

4

The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experience.

Jonak C, Raderer M, Zacherl J, Prager G, Troch M, Ba-Ssalamah A, Hejna M. Jonak C, et al. Anticancer Res. 2008 Nov-Dec;28(6B):4101-4. Anticancer Res. 2008. PMID: 19192667 Free article.

5

Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results.

Ba-Ssalamah A, Matzek W, Baroud S, Bastati N, Zacherl J, Schoppmann SF, Hejna M, Wrba F, Weber M, Herold CJ, Gore RM. Ba-Ssalamah A, et al. Eur Radiol. 2011 Nov;21(11):2326-35. doi: 10.1007/s00330-011-2187-2. Epub 2011 Jun 28. Eur Radiol. 2011. PMID: 21710266

6

Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna.

Bojic M, Pluschnig U, Zacherl J, Thallinger CM, Ba-Ssalamah A, Maresch J, Datler P, Schoppmann SF, Hejna M. Bojic M, et al. Anticancer Res. 2011 Jun;31(6):2379-82. Anticancer Res. 2011. PMID: 21737668

7

Downregulation of phosphatidylethanolamine binding protein 1 associates with clinical risk factors in gastrointestinal stromal tumors, but not with activation of the RAF-1-MEK-ETV1 pathway.

Schoppmann SF, Beer A, Nirtl N, Ba-Ssalamah A, Brodowicz T, Streubel B, Birner P. Schoppmann SF, et al. Cancer Lett. 2013 Jul 10;335(1):26-30. doi: 10.1016/j.canlet.2013.01.044. Epub 2013 Jan 31. Cancer Lett. 2013. PMID: 23376254

8

Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma.

Pluschnig U, Schoppmann SF, Preusser M, Datler P, Asari R, Ba-Ssalamah A, Schwameis K, Birner P, Zacherl J, Hejna M. Pluschnig U, et al. Anticancer Res. 2013 Mar;33(3):1035-9. Anticancer Res. 2013. PMID: 23482778

9

The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.

Schwameis K, Ba-Ssalamah A, Wrba F, Birner P, Prager G, Hejna M, Schmid R, Asari R, Zacherl J, Schoppmann SF. Schwameis K, et al. Anticancer Res. 2013 May;33(5):2085-91. Anticancer Res. 2013. PMID: 23645759

10

Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract.

Ilhan-Mutlu A, Preusser M, Schoppmann SF, Asari R, Ba-Ssalamah A, Schwameis K, Pluschnig U, Birner P, Püspök A, Zacherl J, Hejna M. Ilhan-Mutlu A, et al. Anticancer Res. 2013 Aug;33(8):3455-9. Anticancer Res. 2013. PMID: 23898119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters